IST, the barometer index, the S&P BSE Sensex, shed 172.42 points or 0.23% to 76,348.14. The Nifty 50 index lost 69.15 points or 0.30% to 23,136.20.
IST, the barometer index, the S&P BSE Sensex rose 154.28 points or 0.20% to 76,559.27. The Nifty 50 index added 64.95 points or 0.28% to 23,220.30.
Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The designation ...
The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb trial of its oral NLRP3 inflammasome inhibitor, Usnoflast, for ...
Zydus, a leading, discovery-based, global pharmaceutical company announced that the US FDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of ...
Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...
When Donald Trump departed the White House in January 2021 at the end of his first presidential term, a return to the nation’s highest office seemed out of the question to many political observers.
People walk with belongings after crossing the Oskil River bridge while fleeing the frontline town of Kupiansk, Kharkiv region, on September 24, 2022, amid Russia's military invasion on Ukraine. - In ...
To produce Trump’s Comeback, the FRONTLINE team drew on nearly a decade of reporting on Donald Trump, and conducted seven new interviews with journalists as well as current and former Trump ...
Zydus Lifesciences has been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 2b trial testing its experimental oral treatment usnoflast in people with amyotrophic lateral ...
Zydus Lifesciences's Usnoflast receives Orphan Drug Designation from the USFDA for the treatment of Amyotrophic Lateral Sclerosis (ALS), a rare neurodegenerative disease. New Delhi, Jan 22 (PTI) Zydus ...